Holen Sie sich die Stockscreener-App
6.48
2.56%
-0.17
Schlusskurs vom Vortag:
$6.65
Offen:
$6.71
24-Stunden-Volumen:
181.41K
Relative Volume:
0.28
Marktkapitalisierung:
$350.51M
Einnahmen:
$2.81M
Nettoeinkommen (Verlust:
$-97.34M
KGV:
-4.1013
EPS:
-1.58
Netto-Cashflow:
$-91.47M
1W Leistung:
-5.81%
1M Leistung:
-14.62%
6M Leistung:
+92.28%
1J Leistung:
-25.86%
1-Tages-Spanne:
$6.40
$6.71
1-Wochen-Bereich:
$6.35
$6.88
52-Wochen-Spanne:
$2.315
$9.30
Fulcrum Therapeutics Inc Stock (FULC) Company Profile
Firmenname
Fulcrum Therapeutics Inc
Sektor
Branche
Telefon
617-651-8851
Adresse
26 LANDSDOWNE STREET, CAMBRIDGE, MA
Vergleichen Sie FULC mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
FULC
Fulcrum Therapeutics Inc
|
6.48 | 359.71M | 2.81M | -97.34M | -91.47M | -1.58 |
|
VRTX
Vertex Pharmaceuticals Inc
|
391.02 | 100.52B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
580.70 | 61.43B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
446.51 | 59.29B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
712.20 | 43.09B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
306.05 | 35.42B | 3.81B | -644.79M | -669.77M | -6.24 |
Fulcrum Therapeutics Inc Stock (FULC) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-07-29 | Hochstufung | H.C. Wainwright | Neutral → Buy |
| 2025-05-23 | Hochstufung | Leerink Partners | Market Perform → Outperform |
| 2025-05-15 | Hochstufung | Cantor Fitzgerald | Neutral → Overweight |
| 2024-09-13 | Herabstufung | H.C. Wainwright | Buy → Neutral |
| 2024-09-12 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2024-09-12 | Herabstufung | Cantor Fitzgerald | Overweight → Neutral |
| 2024-09-12 | Herabstufung | Leerink Partners | Outperform → Market Perform |
| 2024-09-12 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2024-09-12 | Herabstufung | Stifel | Buy → Hold |
| 2024-09-09 | Hochstufung | BofA Securities | Underperform → Neutral |
| 2024-05-20 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2024-03-13 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2023-09-25 | Eingeleitet | Goldman | Neutral |
| 2023-08-23 | Hochstufung | H.C. Wainwright | Neutral → Buy |
| 2023-08-22 | Hochstufung | Stifel | Hold → Buy |
| 2023-05-04 | Herabstufung | Goldman | Buy → Neutral |
| 2023-03-10 | Herabstufung | Credit Suisse | Outperform → Neutral |
| 2023-03-10 | Herabstufung | H.C. Wainwright | Buy → Neutral |
| 2023-03-09 | Herabstufung | Stifel | Buy → Hold |
| 2023-02-28 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2023-02-24 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2022-11-15 | Eingeleitet | Goldman | Buy |
| 2022-03-08 | Eingeleitet | Oppenheimer | Outperform |
| 2022-03-03 | Hochstufung | BofA Securities | Underperform → Neutral |
| 2021-08-11 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2021-04-26 | Fortgesetzt | Credit Suisse | Outperform |
| 2021-03-22 | Eingeleitet | Credit Suisse | Outperform |
| 2021-03-02 | Eingeleitet | Stifel | Buy |
| 2020-10-16 | Eingeleitet | Piper Sandler | Overweight |
| 2020-08-12 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2020-08-12 | Bestätigt | H.C. Wainwright | Buy |
| 2020-08-12 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2020-06-19 | Herabstufung | BofA/Merrill | Buy → Neutral |
| 2020-06-17 | Eingeleitet | BTIG Research | Buy |
| 2019-10-03 | Eingeleitet | H.C. Wainwright | Buy |
| 2019-08-12 | Eingeleitet | BofA/Merrill | Buy |
Alle ansehen
Fulcrum Therapeutics Inc Aktie (FULC) Neueste Nachrichten
Using Ichimoku Cloud for Fulcrum Therapeutics Inc. technicalsNew Guidance & High Conviction Investment Ideas - Newser
Is this a good reentry point in Fulcrum Therapeutics Inc.Quarterly Profit Review & Long Hold Capital Preservation Plans - Newser
Evaluating Fulcrum Therapeutics Inc. with trendline analysisJuly 2025 Big Picture & Safe Capital Growth Trade Ideas - Newser
Fulcrum Therapeutics Inc. stock prediction for this weekWeekly Investment Recap & Fast Moving Market Watchlists - Newser
Fulcrum Therapeutics Inc. stock daily chart insights2025 Investor Takeaways & Daily Technical Stock Forecast Reports - Newser
Applying big data sentiment scoring on Fulcrum Therapeutics Inc.Market Trend Review & Low Risk Profit Maximizing Plans - Newser
Analyzing Fulcrum Therapeutics Inc. with risk reward ratio chartsTreasury Yields & AI Powered Trade Plan Recommendations - Newser
Exit strategy if you’re trapped in Fulcrum Therapeutics Inc.Market Performance Summary & Consistent Growth Stock Picks - Newser
Will Fulcrum Therapeutics Inc. benefit from macro trendsLong Setup & Expert Approved Momentum Trade Ideas - Newser
Combining machine learning predictions for Fulcrum Therapeutics Inc.2025 Trading Volume Trends & Community Trade Idea Sharing - Newser
Will Fulcrum Therapeutics Inc. see short term momentumJuly 2025 Movers & Accurate Intraday Trading Signals - Newser
Market reaction to Fulcrum Therapeutics Inc.’s recent news2025 Trade Ideas & Verified Swing Trading Watchlist - Newser
Using Bollinger Bands to evaluate Fulcrum Therapeutics Inc.2025 Earnings Surprises & Verified Technical Trade Signals - Newser
Real time pattern detection on Fulcrum Therapeutics Inc. stockTrade Ideas & Verified Chart Pattern Trade Signals - Newser
How high can Fulcrum Therapeutics Inc. stock go2025 Growth vs Value & Fast Exit Strategy with Risk Control - Newser
Measuring Fulcrum Therapeutics Inc.’s beta against major indicesJuly 2025 Pullbacks & Free Safe Capital Growth Stock Tips - Newser
Is Fulcrum Therapeutics Inc. meeting your algorithmic filter criteriaIndex Update & High Conviction Buy Zone Alerts - Newser
Is Fulcrum Therapeutics Inc. reversing from oversold territoryMarket Activity Report & Free Technical Confirmation Trade Alerts - Newser
Relative strength of Fulcrum Therapeutics Inc. in sector analysisWeekly Loss Report & Risk Adjusted Swing Trade Ideas - Newser
Building trade automation scripts for Fulcrum Therapeutics Inc.July 2025 Institutional & Long-Term Investment Growth Plans - Newser
Will earnings trigger a reversal in Fulcrum Therapeutics Inc.Rate Cut & Risk Adjusted Buy/Sell Alerts - Newser
How to interpret RSI for Fulcrum Therapeutics Inc. stockJuly 2025 Levels & Real-Time Buy Signal Alerts - Newser
Fulcrum Therapeutics shares fall 1.88% intraday after corporate presentation in August 2025. - AInvest
Chart overlay techniques for tracking Fulcrum Therapeutics Inc.2025 Fundamental Recap & AI Driven Stock Reports - Newser
Is Fulcrum Therapeutics Inc. stock reversal real or fakeJuly 2025 Decliners & High Conviction Buy Zone Picks - Newser
Finanzdaten der Fulcrum Therapeutics Inc-Aktie (FULC)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.96%
1.09%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):